Name-Brand Manufacturers Not Liable for Generic Reglan Injuries



DOCUMENTS
  • Opinion


BEAUMONT, Texas - Under Texas law, a brand-name drug manufacturer may not be held liable on a failure-to-warn claim asserted by a plaintiff who ingested generic Reglan that was manufactured by another company, a Texas federal judge has ruled. Finnicum v. Wyeth Inc., No. 1:09-785 (E.D. Texas).

In her April 28 decision, Judge Marcia A. Crone of the U.S. District Court for the Eastern District of Texas relied upon rulings by the Texas Supreme Court that product liability is precluded when the defendant did not supply the product that caused the alleged injury.

Judith Finnicum sued various drug manufacturers, including …






UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS



HarrisMartin's MDL Conference

December 04, 2024 - New York, NY
Virgin Hotels NYC

MORE DETAILS